U.S. market Closed. Opens in 16 hours 59 minutes

CGTX | Cognition Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue252.00K235.00K93.00K98.00K81.00K
Gross Profit-252.00K-235.00K-93.00K-98.00K-81.00K
Operating Expenses50.47M21.33M11.15M6.55M4.67M
Selling, General & Admin13.28M13.23M10.03M4.52M3.45M
Research & Development37.20M30.32M18.57M12.89M14.38M
Other Operating ExpensesN/A-22.22M-17.45M-10.86M-13.16M
Operating Income-50.72M-43.55M-28.60M-17.41M-17.83M
Other Expenses / Income24.94M22.15M16.88M9.57M12.99M
Before Tax Income-25.79M-21.40M-11.72M-7.84M-4.84M
Income Tax ExpensesN/A-22.15M-1.43M2.23M2.11M
Net Income-25.79M757.00K-10.29M-10.07M-6.95M
Interest Expenses-27.00K28.00K893.00K1.75M1.02M
Basic Shares Outstanding30.03M28.99M22.23M21.94M21.94M
Diluted Shares Outstanding30.03M28.99M22.23M21.94M21.94M
EBITDA-50.47M-21.13M-13.38M-5.97M-3.50M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-25.82M-21.37M-10.82M-6.09M-3.82M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙